Find a Tender
complete
Official procurement procedure
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
No classification published
Location not published
Published value
£160,000,000
Submission deadline 6 Feb 2026, 13:00 GMT
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives". Published status: complete. Published value: £160,000,000. 1 published lot. Recorded submission deadline: 6 Feb 2026, 13:00 GMT. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Closed 6 Feb 2026, 13:00 GMT |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £160,000,000 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published7 Apr 2026, 16:16 BST | Last source update7 Apr 2026, 16:16 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-05cf3b | ||
What is being bought
Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026
Offer reference number: CM/TNS/25/5737
Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
What changed
From the official release history
- Official notice release published
7 Apr 2026, 16:16 BST - tender value changed
26 Feb 2026, 15:59 GMT - Status changed to complete
26 Feb 2026, 15:59 GMT - Official notice release published
26 Feb 2026, 15:59 GMT - Submission deadline changed to published date
26 Feb 2026, 15:59 GMT - Official notice release published
28 Jan 2026, 12:58 GMT - Submission deadline changed to 6 Feb 2026, 13:00 GMT
28 Jan 2026, 12:58 GMT - Status changed to active
22 Dec 2025, 16:55 GMT - Official notice release published
22 Dec 2025, 16:55 GMT - Submission deadline changed to 30 Jan 2026, 13:00 GMT
22 Dec 2025, 16:55 GMT - Published value updated to £160,000,000
17 Oct 2025, 16:37 BST - Status changed to planning
17 Oct 2025, 16:37 BST - Official notice release published
17 Oct 2025, 16:37 BST - Buyer information updated
17 Oct 2025, 16:37 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
7 Apr 2026, 16:16 BST - Submission deadline
6 Feb 2026, 13:00 GMT - Award active
Not published · Not published - Contract active
Signed 11 Mar 2026, 00:00 GMT · £160,000,000
Commercial outcome and competition
Awards ABBVIE LTD, GILEAD SCIENCES LTD Not published · Not published · active |
Contracts NHS England procurement for the supply of pangenotypic Hepatitis C treatments and the provision of Hepatitis C elimination initiatives £160,000,000 · signed 11 Mar 2026, 00:00 GMT · active Contract period: 1 Apr 2026, 00:00 BST — 31 Mar 2028, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published